Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. urological
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Urological Articles & Analysis

153 news found

The Dutch Government Elects to Sponsor the ENFORCE Trial - A Fully Funded RCT That Includes the Nanoknife System for Prostate Treatment

The Dutch Government Elects to Sponsor the ENFORCE Trial - A Fully Funded RCT That Includes the Nanoknife System for Prostate Treatment

We are pleased to offer congratulations to Professor Jurgen Fütterer and his team at Radboud University Medical Centre in the Netherlands, for having successfully secured €3.8 million from the Dutch National Health Care Institute and ZonMw towards the ENFORCE trial, a fully funded Randomised Controled Trial for Focal Therapy which incorporates the NanoKnife System as a treatment option ...

ByAngioDynamics, Inc.


With Policy Support, the Market for Surgical Robots Grows

With Policy Support, the Market for Surgical Robots Grows

While enhancing surgical results and improving the working environment of doctors, surgical robotics can further reduce patient trauma and achieve more safe, reliable and repeatable surgical treatments.Classification of surgical robotsThe precise positioning and movements of surgical robots enable them to play an important role in surgical scenarios that require delicate operations, and thus have ...

ByShenzhen Yujiaxin Tech Co., Ltd


Press release: High quality, cost effective surgical retractor is welcomed by leading US hospital group

Press release: High quality, cost effective surgical retractor is welcomed by leading US hospital group

Its Galaxy II self-retaining retractor was first developed to dramatically improve comfort and visualization for the operating room (OR) team during gynecological and urological surgery, but it has since been rapidly adopted by all surgical disciplines. ...

ByJUNE Medical USA Inc


Nubeqa (darolutamide) receives EU approval for additional indication in prostate cancer

Nubeqa (darolutamide) receives EU approval for additional indication in prostate cancer

“The approval of Nubeqa in mHSPC in Europe is a major step forward for patients and their treating physicians, expanding the treatment options available and our ability to improve clinical outcomes for those living with the disease,” said Prof. Bertrand Tombal, Professor of Urology at the Université catholique de Louvain (UCL), Cliniques universitaires ...

ByBayer AG


miR Scientific and Leonie Hill Capital Announce Collaboration to Introduce Breakthrough Urine Liquid Biopsy Prostate Cancer Test in Singapore

miR Scientific and Leonie Hill Capital Announce Collaboration to Introduce Breakthrough Urine Liquid Biopsy Prostate Cancer Test in Singapore

High demand seen for effective disease management platform for second most common cancer in Singaporean men NEW YORK and SINGAPORE, March 28, 2022 /PRNewswire/ -- miR Scientific, a New York-based healthcare company dedicated to transforming global cancer management, and Leonie Hill Capital, a Singapore-based organization focused on large-scale, sophisticated healthcare access and distribution, ...

BymiR Scientific, LLC


FARCO-PHARMA initiates sales in the U.S.

FARCO-PHARMA initiates sales in the U.S.

As the German specialist for sterile urological lubricants, we have now made it our goal to expand sales within the U.S. market in collaboration with a sales and distribution partner. ...

ByFARCO-PHARMA GmbH


TURP Primer - Transurethral resection of the prostate

TURP Primer - Transurethral resection of the prostate

The TURP Primer is especially geared towards all urologists and their assistants who are interested in learning how to perform TURP or who are already performing TURP and would like to deepen their understanding of the physical and technical fundamentals. This primer is available in German language and provides an overview of the most important TURP developments of the past 20 years to today. In ...

ByFARCO-PHARMA GmbH


Guidelines for the diagnosis, treatment and metaphylaxis of urolithiasis

Guidelines for the diagnosis, treatment and metaphylaxis of urolithiasis

Updated reprint – exclusively available from FARCO-PHARMA The Urinary Stones Working Group of the Academy of German Urologists, the Deutsche Gesellschaft für Urologie e. V. [German Society of Urology], and the Berufsverband der Deutschen Urologen e. V. [Professional Association of German Urologists], under the direction of Prof. ...

ByFARCO-PHARMA GmbH


CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer

CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer

It is therefore critical that these patients have access to treatment options that can not only improve mortality but also delay the time to symptom progression," said Prof. Bertrand Tombal, Professor of Urology at the Université catholique de Louvain (UCL), Cliniques universitaires Saint-Luc, Brussels, Belgium. ...

ByBayer AG


I Lost One of the Most Vital Organs - Prostate Cancer Patient Stories

I Lost One of the Most Vital Organs - Prostate Cancer Patient Stories

Prostate cancer is the most common type of cancer in men. Every year this diagnosis is made about 900 thousand times, in developed countries the disease affects up to 14% of the entire male population with oncology due to longer life expectancy. We spoke with adult prostate cancer survivors. ...

ByProUroCare Medical Inc.


Announcement – New Urological AI Tool for 3D Reconstruction of the Ureter

Announcement – New Urological AI Tool for 3D Reconstruction of the Ureter

This new vendor-neutral technology will be available to third-party medical device manufacturers using C-arm imaging and viewer solutions, providing an advanced 3D tool for a variety of urologic procedures. “Creating a 3D model from 2D images is a challenging task and requires vast experience and ...

ByRSIP Vision


FDA Approves Taiho’s LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

FDA Approves Taiho’s LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

Taiho Pharmaceutical also has development programs in allergy and immunology, urology and consumer healthcare products. Our corporate philosophy is simple: “We strive to improve human health and contribute to a society enriched by ...

ByTaiho Oncology, Inc.


New partner  Continentia Association

New partner Continentia Association

The Association, created by a group of specialists in the field of urology, focused on research of incontinence-related diseases and professional training in this field. ...

ByRethink Medical S.L.


Creative Medical Technology Announces Positive Top-Line Results for StemSpine Pilot Study

Creative Medical Technology Announces Positive Top-Line Results for StemSpine Pilot Study

("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced positive two-year follow-up data for the Company's StemSpine® pilot study, showing significant efficacy of the StemSpine® procedure for treating chronic ...

ByCreative Medical Technology Holdings, Inc. (CELZ)


Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine Study

Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine Study

("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, neurology, and orthopedics, today announced the peer reviewed publication of positive, two-year follow-up data for the Company's StemSpine® study, showing significant efficacy of the StemSpine® ...

ByCreative Medical Technology Holdings, Inc. (CELZ)


Integrating Fusion Biopsies into Your Practice II

Integrating Fusion Biopsies into Your Practice II

In the long run, it is better for urology practices to adopt fusion, but for the 50%+ lacking the upfront capital, imaging centers could provide an appealing stopgap. Without the immediate financial incentive, most urology practices are unable to afford or justify the cost of acquiring the technology. ...

ByFocal Healthcare


Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer

Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer

Taiho Pharmaceutical also has development programs in allergy and immunology, urology and consumer healthcare products. Our corporate philosophy is simple: “We strive to improve human health and contribute to a society enriched by ...

ByTaiho Oncology, Inc.


New ARASENS data reinforce strong tolerability profile of darolutamide plus ADT and docetaxel without compromising quality of life for patients with mHSPC

New ARASENS data reinforce strong tolerability profile of darolutamide plus ADT and docetaxel without compromising quality of life for patients with mHSPC

“For those diagnosed with advanced prostate cancer, it is crucial to find a treatment that is not only effective but allows them to safely preserve their quality of life,” said Bertrand Tombal, M.D., Ph.D., Professor of Urology, Université catholique de Louvain (UCL), Cliniques universitaires, Saint-Luc, Brussels, Belgium. ...

ByBayer AG


BlueWind Medical Ltd. Makes Key Additions to Leadership Team

BlueWind Medical Ltd. Makes Key Additions to Leadership Team

About Overactive Bladder and Urinary Urgency Incontinence: According to the American Urological Association, OAB is a chronic, debilitating condition affecting over 33 million Americans. ...

ByBlueWind Medical


Interim results of the Expander-1 Clinical Study

Interim results of the Expander-1 Clinical Study

There is a strong need for an alternative minimally-invasive solutions that offer rapid relief from BPH/LUTS and have no risk of urinary incontinence or impact on sexual function,” said Dr. Henry Woo, a world-renowned urological surgeon and Professor of Surgery at the University of Sydney, Australia. ...

ByProdeon Medical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT